Noradrenergic antagonism enhances the conditioned aversive effects of cocaine
The propensity to self-administer cocaine may be a function of both its positively reinforcing and aversive effects, with the latter acting as a limiting factor on overall drug taking. However, relative to what is known about the physiological underpinnings of cocaine's positively reinforcing e...
Gespeichert in:
Veröffentlicht in: | Pharmacology, biochemistry and behavior biochemistry and behavior, 2008-02, Vol.88 (4), p.523-532 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 532 |
---|---|
container_issue | 4 |
container_start_page | 523 |
container_title | Pharmacology, biochemistry and behavior |
container_volume | 88 |
creator | Freeman, Kevin B. Verendeev, Andrey Riley, Anthony L. |
description | The propensity to self-administer cocaine may be a function of both its positively reinforcing and aversive effects, with the latter acting as a limiting factor on overall drug taking. However, relative to what is known about the physiological underpinnings of cocaine's positively reinforcing effects, little is known about its aversive effects. There is some evidence that cocaine's aversive effects, as indexed in the conditioned taste aversion (CTA) preparation, are catecholaminergically mediated, i.e., through cocaine's actions on the dopaminergic and noradrenergic neurotransmitter systems. Although limited evidence suggests a role for dopamine, there has yet to be a direct assessment of noradrenergic involvement. To better characterize a role for this system, cocaine-induced CTAs (10, 18 and 32 mg/kg) were conducted under conditions of antagonism at the norepinephrine α
1 and β receptors using prazosin (0.3 mg/kg; Experiment 2) and propranolol (10 mg/kg; Experiment 3), respectively, at doses that were determined to be non-aversive (Experiment 1). In each case of noradrenergic antagonism, CTAs with cocaine were not attenuated, suggesting that this drug's conditioned aversive effects are mediated by non-noradrenergic NT activity. Furthermore, prazosin and propranolol administration appeared to facilitate the conditioned aversive effects of cocaine. The implications of these findings in regards to other neurochemical processes are discussed. |
doi_str_mv | 10.1016/j.pbb.2007.10.011 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70166544</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091305707003231</els_id><sourcerecordid>70166544</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-29f1c9b6aec562969cdb81a79385df78f63d73a8ea5a517f8775e09732b90263</originalsourceid><addsrcrecordid>eNqFkMFOGzEQQK2qqKShH9AL2gu9bfDYu_ZaPVWo0EoULrlbXnsMjhI72JtI_D2OEokbPY1m5s1o5hHyHegCKIjr1WI7jgtGqaz5ggJ8IjMYJG97kPIzmVGqoOW0l-fkaykrSmnHhPxCzmGgXS8km5F_DykblzFifgq2MXEyTymGsmkwPptosTTTMzY2RRemkCK6xuwxl7DHBr1HO5Um-dq3JkS8IGferAt-O8U5Wd7-Xt78ae8f7_7e_LpvbQdsapnyYNUoDNpeMCWUdeMARio-9M7LwQvuJDcDmt7UV_wgZY9USc5GRZngc_LjuHab08sOy6Q3oVhcr03EtCtaVjmi77r_gowKBsBlBeEI2pxKyej1NoeNya8aqD641itdXeuD60Opuq4zl6flu3GD7n3iJLcCVyfAFGvWPlefobxzSikuQVXu55HDqmwfMOtiA1b3LuQqWLsUPjjjDXKQm60</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20621137</pqid></control><display><type>article</type><title>Noradrenergic antagonism enhances the conditioned aversive effects of cocaine</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Freeman, Kevin B. ; Verendeev, Andrey ; Riley, Anthony L.</creator><creatorcontrib>Freeman, Kevin B. ; Verendeev, Andrey ; Riley, Anthony L.</creatorcontrib><description>The propensity to self-administer cocaine may be a function of both its positively reinforcing and aversive effects, with the latter acting as a limiting factor on overall drug taking. However, relative to what is known about the physiological underpinnings of cocaine's positively reinforcing effects, little is known about its aversive effects. There is some evidence that cocaine's aversive effects, as indexed in the conditioned taste aversion (CTA) preparation, are catecholaminergically mediated, i.e., through cocaine's actions on the dopaminergic and noradrenergic neurotransmitter systems. Although limited evidence suggests a role for dopamine, there has yet to be a direct assessment of noradrenergic involvement. To better characterize a role for this system, cocaine-induced CTAs (10, 18 and 32 mg/kg) were conducted under conditions of antagonism at the norepinephrine α
1 and β receptors using prazosin (0.3 mg/kg; Experiment 2) and propranolol (10 mg/kg; Experiment 3), respectively, at doses that were determined to be non-aversive (Experiment 1). In each case of noradrenergic antagonism, CTAs with cocaine were not attenuated, suggesting that this drug's conditioned aversive effects are mediated by non-noradrenergic NT activity. Furthermore, prazosin and propranolol administration appeared to facilitate the conditioned aversive effects of cocaine. The implications of these findings in regards to other neurochemical processes are discussed.</description><identifier>ISSN: 0091-3057</identifier><identifier>EISSN: 1873-5177</identifier><identifier>DOI: 10.1016/j.pbb.2007.10.011</identifier><identifier>PMID: 18045672</identifier><identifier>CODEN: PBBHAU</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adrenergic alpha-Antagonists - pharmacology ; Adrenergic beta-Antagonists - pharmacology ; Animals ; Avoidance Learning - drug effects ; Biological and medical sciences ; Cocaine ; Cocaine - pharmacology ; Conditioned taste aversion ; Conditioning, Operant - drug effects ; Dopamine Uptake Inhibitors - pharmacology ; Dose-Response Relationship, Drug ; Male ; Medical sciences ; Neuropharmacology ; Norepinephrine ; Norepinephrine - antagonists & inhibitors ; Pharmacology. Drug treatments ; Prazosin ; Prazosin - pharmacology ; Propanolol ; Propranolol - pharmacology ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Rats ; Rats, Sprague-Dawley ; Sympathetic Nervous System - drug effects ; Taste - drug effects</subject><ispartof>Pharmacology, biochemistry and behavior, 2008-02, Vol.88 (4), p.523-532</ispartof><rights>2007 Elsevier Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-29f1c9b6aec562969cdb81a79385df78f63d73a8ea5a517f8775e09732b90263</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0091305707003231$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19993719$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18045672$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Freeman, Kevin B.</creatorcontrib><creatorcontrib>Verendeev, Andrey</creatorcontrib><creatorcontrib>Riley, Anthony L.</creatorcontrib><title>Noradrenergic antagonism enhances the conditioned aversive effects of cocaine</title><title>Pharmacology, biochemistry and behavior</title><addtitle>Pharmacol Biochem Behav</addtitle><description>The propensity to self-administer cocaine may be a function of both its positively reinforcing and aversive effects, with the latter acting as a limiting factor on overall drug taking. However, relative to what is known about the physiological underpinnings of cocaine's positively reinforcing effects, little is known about its aversive effects. There is some evidence that cocaine's aversive effects, as indexed in the conditioned taste aversion (CTA) preparation, are catecholaminergically mediated, i.e., through cocaine's actions on the dopaminergic and noradrenergic neurotransmitter systems. Although limited evidence suggests a role for dopamine, there has yet to be a direct assessment of noradrenergic involvement. To better characterize a role for this system, cocaine-induced CTAs (10, 18 and 32 mg/kg) were conducted under conditions of antagonism at the norepinephrine α
1 and β receptors using prazosin (0.3 mg/kg; Experiment 2) and propranolol (10 mg/kg; Experiment 3), respectively, at doses that were determined to be non-aversive (Experiment 1). In each case of noradrenergic antagonism, CTAs with cocaine were not attenuated, suggesting that this drug's conditioned aversive effects are mediated by non-noradrenergic NT activity. Furthermore, prazosin and propranolol administration appeared to facilitate the conditioned aversive effects of cocaine. The implications of these findings in regards to other neurochemical processes are discussed.</description><subject>Adrenergic alpha-Antagonists - pharmacology</subject><subject>Adrenergic beta-Antagonists - pharmacology</subject><subject>Animals</subject><subject>Avoidance Learning - drug effects</subject><subject>Biological and medical sciences</subject><subject>Cocaine</subject><subject>Cocaine - pharmacology</subject><subject>Conditioned taste aversion</subject><subject>Conditioning, Operant - drug effects</subject><subject>Dopamine Uptake Inhibitors - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Norepinephrine</subject><subject>Norepinephrine - antagonists & inhibitors</subject><subject>Pharmacology. Drug treatments</subject><subject>Prazosin</subject><subject>Prazosin - pharmacology</subject><subject>Propanolol</subject><subject>Propranolol - pharmacology</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sympathetic Nervous System - drug effects</subject><subject>Taste - drug effects</subject><issn>0091-3057</issn><issn>1873-5177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMFOGzEQQK2qqKShH9AL2gu9bfDYu_ZaPVWo0EoULrlbXnsMjhI72JtI_D2OEokbPY1m5s1o5hHyHegCKIjr1WI7jgtGqaz5ggJ8IjMYJG97kPIzmVGqoOW0l-fkaykrSmnHhPxCzmGgXS8km5F_DykblzFifgq2MXEyTymGsmkwPptosTTTMzY2RRemkCK6xuwxl7DHBr1HO5Um-dq3JkS8IGferAt-O8U5Wd7-Xt78ae8f7_7e_LpvbQdsapnyYNUoDNpeMCWUdeMARio-9M7LwQvuJDcDmt7UV_wgZY9USc5GRZngc_LjuHab08sOy6Q3oVhcr03EtCtaVjmi77r_gowKBsBlBeEI2pxKyej1NoeNya8aqD641itdXeuD60Opuq4zl6flu3GD7n3iJLcCVyfAFGvWPlefobxzSikuQVXu55HDqmwfMOtiA1b3LuQqWLsUPjjjDXKQm60</recordid><startdate>20080201</startdate><enddate>20080201</enddate><creator>Freeman, Kevin B.</creator><creator>Verendeev, Andrey</creator><creator>Riley, Anthony L.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20080201</creationdate><title>Noradrenergic antagonism enhances the conditioned aversive effects of cocaine</title><author>Freeman, Kevin B. ; Verendeev, Andrey ; Riley, Anthony L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-29f1c9b6aec562969cdb81a79385df78f63d73a8ea5a517f8775e09732b90263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adrenergic alpha-Antagonists - pharmacology</topic><topic>Adrenergic beta-Antagonists - pharmacology</topic><topic>Animals</topic><topic>Avoidance Learning - drug effects</topic><topic>Biological and medical sciences</topic><topic>Cocaine</topic><topic>Cocaine - pharmacology</topic><topic>Conditioned taste aversion</topic><topic>Conditioning, Operant - drug effects</topic><topic>Dopamine Uptake Inhibitors - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Norepinephrine</topic><topic>Norepinephrine - antagonists & inhibitors</topic><topic>Pharmacology. Drug treatments</topic><topic>Prazosin</topic><topic>Prazosin - pharmacology</topic><topic>Propanolol</topic><topic>Propranolol - pharmacology</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sympathetic Nervous System - drug effects</topic><topic>Taste - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Freeman, Kevin B.</creatorcontrib><creatorcontrib>Verendeev, Andrey</creatorcontrib><creatorcontrib>Riley, Anthony L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacology, biochemistry and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Freeman, Kevin B.</au><au>Verendeev, Andrey</au><au>Riley, Anthony L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Noradrenergic antagonism enhances the conditioned aversive effects of cocaine</atitle><jtitle>Pharmacology, biochemistry and behavior</jtitle><addtitle>Pharmacol Biochem Behav</addtitle><date>2008-02-01</date><risdate>2008</risdate><volume>88</volume><issue>4</issue><spage>523</spage><epage>532</epage><pages>523-532</pages><issn>0091-3057</issn><eissn>1873-5177</eissn><coden>PBBHAU</coden><abstract>The propensity to self-administer cocaine may be a function of both its positively reinforcing and aversive effects, with the latter acting as a limiting factor on overall drug taking. However, relative to what is known about the physiological underpinnings of cocaine's positively reinforcing effects, little is known about its aversive effects. There is some evidence that cocaine's aversive effects, as indexed in the conditioned taste aversion (CTA) preparation, are catecholaminergically mediated, i.e., through cocaine's actions on the dopaminergic and noradrenergic neurotransmitter systems. Although limited evidence suggests a role for dopamine, there has yet to be a direct assessment of noradrenergic involvement. To better characterize a role for this system, cocaine-induced CTAs (10, 18 and 32 mg/kg) were conducted under conditions of antagonism at the norepinephrine α
1 and β receptors using prazosin (0.3 mg/kg; Experiment 2) and propranolol (10 mg/kg; Experiment 3), respectively, at doses that were determined to be non-aversive (Experiment 1). In each case of noradrenergic antagonism, CTAs with cocaine were not attenuated, suggesting that this drug's conditioned aversive effects are mediated by non-noradrenergic NT activity. Furthermore, prazosin and propranolol administration appeared to facilitate the conditioned aversive effects of cocaine. The implications of these findings in regards to other neurochemical processes are discussed.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>18045672</pmid><doi>10.1016/j.pbb.2007.10.011</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-3057 |
ispartof | Pharmacology, biochemistry and behavior, 2008-02, Vol.88 (4), p.523-532 |
issn | 0091-3057 1873-5177 |
language | eng |
recordid | cdi_proquest_miscellaneous_70166544 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adrenergic alpha-Antagonists - pharmacology Adrenergic beta-Antagonists - pharmacology Animals Avoidance Learning - drug effects Biological and medical sciences Cocaine Cocaine - pharmacology Conditioned taste aversion Conditioning, Operant - drug effects Dopamine Uptake Inhibitors - pharmacology Dose-Response Relationship, Drug Male Medical sciences Neuropharmacology Norepinephrine Norepinephrine - antagonists & inhibitors Pharmacology. Drug treatments Prazosin Prazosin - pharmacology Propanolol Propranolol - pharmacology Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Rats Rats, Sprague-Dawley Sympathetic Nervous System - drug effects Taste - drug effects |
title | Noradrenergic antagonism enhances the conditioned aversive effects of cocaine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A37%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Noradrenergic%20antagonism%20enhances%20the%20conditioned%20aversive%20effects%20of%20cocaine&rft.jtitle=Pharmacology,%20biochemistry%20and%20behavior&rft.au=Freeman,%20Kevin%20B.&rft.date=2008-02-01&rft.volume=88&rft.issue=4&rft.spage=523&rft.epage=532&rft.pages=523-532&rft.issn=0091-3057&rft.eissn=1873-5177&rft.coden=PBBHAU&rft_id=info:doi/10.1016/j.pbb.2007.10.011&rft_dat=%3Cproquest_cross%3E70166544%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20621137&rft_id=info:pmid/18045672&rft_els_id=S0091305707003231&rfr_iscdi=true |